The Authority of Social Contribution – Ma’an, the Abu Dhabi Government’s official channel to receive social contributions, and the Pharmaceutical Research and Manufacturers Association in Gulf (PHRMAG), the region’s leading innovative biopharmaceutical research companies, announced a strategic collaboration aimed at enabling access for oncology and rare disease patients most in need to innovative solutions and modern treatments, within an integrated framework aligned with the national health insurance system. The collaboration brings together public and private sector to address a pressing issue, with a shared commitment to providing long-term impact, and continued care delivery for targeted patients. It further strengthens family stability resilience when facing health challenges, while contributing to broader social cohesion and supporting the objectives of the Year of the Family. Abdullah Al Ameri, Director General of the Authority of Social Contribution — Ma’an, said, “Our collaboration with PHRMAG represents a strategic step towards establishing a long-term and integrated healthcare system for oncology and rare disease patients in Abu Dhabi, reflecting our commitment to supporting key social priorities that matter to community members, particularly in the healthcare sector. “At the Authority of Social Contribution — Ma’an, we are committed to directing social contributions and efforts towards creating tangible impact in the lives of the community members, including patients with complex medical conditions. This collaboration reflects a model of integrated roles between the public and private sectors, by leveraging the expertise of companies within ‘PHRMAG’ and unifying their efforts through the Authority’s platform, which ultimately contributes to enhancing access to specialised healthcare services, improving quality of life, and reinforcing the values of shared responsibility and social solidarity.” The Authority will oversee allocation of contributions in line with agreed project milestones. A dedicated committee will also be established to monitor the initiative’s progress through monthly meetings aimed at assessing developments, providing the necessary strategic guidance, and reviewing progress achieved, ensuring effective collaboration and continuous knowledge exchange between both parties throughout the duration of the project. H.E. Mohammed Abdullah Al Awadi, Executive Director of the Health System Financing Regulation Sector at the Department of Health — Abu Dhabi, said, “We are thrilled to witness the collaboration between the Authority of Social Contribution — Ma’an and PHRMAG, which will contribute to supporting our mission of ensuring accessible, world-class healthcare for community members, accelerating innovation and research within the healthcare sector, and advancing the early detection and treatment of rare diseases. This collaboration contributes to building a healthier society with longer, better wellbeing for individuals, while further strengthening Abu Dhabi’s position as a leading destination for innovation in life sciences.” Sameh El Fangary, Chairman of PHRMAG, stated, “As an industry association representing innovative pharmaceutical companies, we are committed to partnering with Abu Dhabi’s health and social authorities to ensure continuity of patients having access to treatment and care when needed. This collaboration with the Authority of Social Contribution – Ma’an reflects our shared ambition to co-create sustainable solutions that improve access to high-quality medical care for those who need it the most from oncology and rare disease patients.” The partnership reflects Abu Dhabi’s ongoing commitment to strengthening collaboration between the public and private sectors, as an effective approach to addressing complex healthcare challenges.
Discover more from ADM | Abu Dhabi Magazine
Subscribe to get the latest posts sent to your email.
Related Post
DoH, Lilly to advance management of obesity, Alzheimer’s disease
Sultan bin Ahmed attends Royal European Academy of Doctors dinner
Abu Dhabi reinforces healthcare leadership with rehabilitation expansion
